Article Outline

• Introduction
• Inhibitors of Cell Wall Synthesis
• • Beta-Lactam Antibiotics
  • Penicillins
  • • Classification, Spectrum of Activity, and Resistance Mechanisms
    • Clinical Use
    • Adverse Effects
  • Cephalosporins
  • • Classification and Spectrum of Activity
    • Clinical Use
    • Adverse Effects
  • Monobactams (Aztreonam)
  • Carbapenems
  • • Spectrum of Activity and Clinical Use
    • Adverse Effects
  • Glycopeptides
  • • Mechanism of Action and Clinical Use
    • Adverse Effects
• Nucleic Acid Inhibitors
• • Fluoroquinolones
  • • Classification and Mechanism of Action
    • Clinical Use
    • Adverse Effects
  • Metronidazole
  • • Mechanism of Action and Spectrum of Activity
    • Clinical Use
    • Adverse Effects
  • Rifamycins
  • • Mechanism of Action and Spectrum of Activity
    • Clinical Use
    • Adverse Effects
  • Trimethoprim-Sulfonamides
  • • Mechanism of Action
    • Clinical Use
    • Adverse Effects
• Protein Synthesis Inhibitors
• • Aminoglycosides
  • • Mechanism of Action
    • Clinical Use
    • Adverse Effects
  • Chloramphenicol
  • • Mechanism of Action and Spectrum of Activity
    • Clinical Use
    • Adverse Effects
  • Macrolides and Lincosamides
  • • Classification and Mechanism of Action
    • Clinical Use
    • Adverse Effects
  • Oxazolidinones (Linezolid)
  • • Mechanism of Action and Spectrum of Activity
  • Tetracyclines
  • • Mechanism of Action
    • Clinical Use
    • Adverse Effects
• References